POCI (Precision Optics) ROCE %: -1.41% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

POCI Precision Optics Corp Inc POCI
73 GF Score
Price $4.45
GF Value $6.34
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Precision Optics ROCE %?

Precision Optics POCI -5.72% 73 ROCE % is -1.41% as of Mar. 2026. GuruFocus rates POCI with a GF Score™ of 73/100 and a GF Value™ of $6.34 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Precision Optics's annualized ROCE % for the quarter that ended in Mar. 2026 was -1.41%.

Precision Optics  (NAS:POCI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Precision Optics ROCE % Related Terms

Precision Optics ROCE % Historical Data

* Premium members only.

The historical data trend for Precision Optics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precision Optics ROCE % Chart

Precision Optics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.79 -9.73 0.57 -20.57 -43.29

Precision Optics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -63.41 -38.40 -44.92 -50.29 -1.41
POCI
73GF Score
Precision Optics Corp Inc POCI
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Precision Optics ROCE % Calculation

Precision Optics's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=-5.551/( ( (16.913 - 4.907) + (19.79 - 6.151) )/ 2 )
=-5.551/( (12.006+13.639)/ 2 )
=-5.551/12.8225
=-43.29 %

Precision Optics's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-0.256/( ( (22.896 - 9.951) + (33.686 - 10.193) )/ 2 )
=-0.256/( ( 12.945 + 23.493 )/ 2 )
=-0.256/18.219
=-1.41 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -1.41% mean?
Precision Optics (POCI) has a ROCE % of -1.41% as of Mar. 2026.
Is Precision Optics' ROCE % too high?
Precision Optics' current ROCE % is -1.41%. Overall, Precision Optics has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Precision Optics' ROCE % compare to DXR and NEPH?
Precision Optics' ROCE % of -1.41% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.26, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Precision Optics's current ROCE % is -1.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precision Optics stock overvalued right now?
Based on GuruFocus' analysis, Precision Optics (POCI) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.34, compared to a current price of $4.45 — trading 29.8% below its estimated fair value. The current ROCE % is -1.41%. Precision Optics' overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Precision Optics (POCI), the current ROCE % is -1.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precision Optics (POCI) Overvalued in 2026?

Based on GuruFocus' analysis, Precision Optics stock appears to be undervalued. The current stock price of $4.45 is trading 29.8% below its estimated GF Value™ of $6.34. GuruFocus considers Precision Optics to be Modestly Undervalued.

Key valuation signals for POCI:

  • ROCE %: -1.41%
  • GF Value™: $6.34 vs. price of $4.45 (29.8% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the POCI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precision Optics Business Description

Address 22 East Broadway, Gardner, MA, USA, 01440
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
73GF Score

Get the complete analysis for POCI

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.45
Price
$6.34
GF Value